{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:59:30Z","timestamp":1789077570248,"version":"build-2803163510"},"reference-count":131,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T00:00:00Z","timestamp":1673740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Western Sydney University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Despite recent advances in oncology, cancer has remained an enormous global health burden, accounting for about 10 million deaths in 2020. A third of the cancer cases in developing counties are caused by microbial infections such as human papillomavirus (HPV), Epstein-Barr Virus (EBV), and hepatitis B and C viruses. EBV, a member of the human gamma herpesvirus family, is a double-stranded DNA virus and the primary cause of infectious mononucleosis. Most EBV infections cause no long-term complications. However, it was reported that EBV infection is responsible for around 200,000 malignancies worldwide every year. Currently, there are no vaccines or antiviral drugs for the prophylaxis or treatment of EBV infection. Recently, the gut microbiota has been investigated for its pivotal roles in pathogen protection and regulating metabolic, endocrine, and immune functions. Several studies have investigated the efficacy of antiviral agents, gut microbial metabolites, and natural products against EBV infection. In this review, we aim to summarise and analyse the reported molecular mechanistic and clinical studies on the activities of gut microbial metabolites and natural medicines against carcinogenic viruses, with a particular emphasis on EBV. Gut microbial metabolites such as short-chain fatty acids were reported to activate the EBV lytic cycle, while bacteriocins, produced by Enterococcus durans strains, have shown antiviral properties. Furthermore, several natural products and dietary bioactive compounds, such as curcumin, epigallocatechin gallate, resveratrol, moronic acid, and andrographolide, have shown antiviral activity against EBV. In this review, we proposed several exciting future directions for research on carcinogenic viruses.<\/jats:p>","DOI":"10.3390\/ijms24021716","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T02:29:55Z","timestamp":1673836195000},"page":"1716","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Fight against the Carcinogenic Epstein-Barr Virus: Gut Microbiota, Natural Medicines, and Beyond"],"prefix":"10.3390","volume":"24","author":[{"given":"Radwa A.","family":"Eladwy","sequence":"first","affiliation":[{"name":"NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang Thi","family":"Vu","sequence":"additional","affiliation":[{"name":"Faculty of Food Science and Technology, Vietnam National University of Agriculture, Trau Quy, Gia Lam, Hanoi 100000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0701-9970","authenticated-orcid":false,"given":"Ravi","family":"Shah","sequence":"additional","affiliation":[{"name":"NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Guang","family":"Li","sequence":"additional","affiliation":[{"name":"NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Chang","sequence":"additional","affiliation":[{"name":"NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9736-0197","authenticated-orcid":false,"given":"Deep Jyoti","family":"Bhuyan","sequence":"additional","affiliation":[{"name":"NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5306\/wjco.v7.i1.54","article-title":"Historical review of the causes of cancer","volume":"7","author":"Blackadar","year":"2016","journal-title":"World J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nrc2961","article-title":"Why do viruses cause cancer? Highlights of the first century of human tumour virology","volume":"10","author":"Moore","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1559325818813227","DOI":"10.1177\/1559325818813227","article-title":"Natural Products Mediated Targeting of Virally Infected Cancer","volume":"17","author":"Fatima","year":"2019","journal-title":"Dose-Response"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.seminoncol.2014.10.003","article-title":"Cancer: \u201ccausation\u201d by infections--individual contributions and synergistic networks","volume":"41","year":"2014","journal-title":"Semin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014Part B: Biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/carcin\/21.3.405","article-title":"Viral carcinogenesis: Revelation of molecular mechanisms and etiology of human disease","volume":"21","author":"Butel","year":"2000","journal-title":"Carcinog."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"20160264","DOI":"10.1098\/rstb.2016.0264","article-title":"Human oncogenic viruses: Nature and discovery","volume":"372","author":"Chang","year":"2017","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bmj.319.7218.1207","article-title":"Infections and human cancer: Cancer surveys, volume 33; microbes and malignancy: Infection as a cause of human cancers","volume":"319","author":"Trichopoulos","year":"1999","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMra0802968","article-title":"Inherited Susceptibility to Common Cancers","volume":"359","author":"Foulkes","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1200\/JCO.2005.10.042","article-title":"Hereditary Cancer Predisposition Syndromes","volume":"23","author":"Garber","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrc.2017.102","article-title":"An evolutionary perspective on field cancerization","volume":"18","author":"Curtius","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/1097-0142(19930801)72:3+<962::AID-CNCR2820721303>3.0.CO;2-H","article-title":"The molecular biology of carcinogenesis","volume":"72","author":"Pitot","year":"1993","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3390\/v6104047","article-title":"Human Viruses and Cancer","volume":"6","year":"2014","journal-title":"Viruses"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/sj.onc.1209612","article-title":"RB, the conductor that orchestrates life, death and differentiation","volume":"25","author":"Khidr","year":"2006","journal-title":"Oncogene"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1126\/science.1138596","article-title":"Protein Composition of Catalytically Active Human Telomerase from Immortal Cells","volume":"315","author":"Cohen","year":"2007","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10175","DOI":"10.1128\/JVI.00321-08","article-title":"Latent Membrane Protein 1 of Epstein-Barr Virus Activates the hTERT Promoter and Enhances Telomerase Activity in B Lymphocytes","volume":"82","author":"Terrin","year":"2008","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2011.12.001","article-title":"The role of miRNAs and EBV BARTs in NPC","volume":"22","author":"Marquitz","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"ref_21","first-page":"1","article-title":"Protumor Activities of the Immune Response: Insights in the Mechanisms of Immunological Shift, Oncotraining, and Oncopromotion","volume":"2013","year":"2013","journal-title":"J. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5858\/arpa.2012-0095-RA","article-title":"Lymphoid Proliferations Associated With Human Immunodeficiency Virus Infection","volume":"137","author":"Chadburn","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.81178","article-title":"The Story of Human Cytomegalovirus and Cancer: Increasing Evidence and Open Questions","volume":"11","author":"Michaelis","year":"2009","journal-title":"Neoplasia"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Andrei, G., Trompet, E., and Snoeck, R. (2019). Novel therapeutics for Epstein\u2013Barr virus. Molecules, 24.","DOI":"10.3390\/molecules24050997"},{"key":"ref_25","first-page":"1","article-title":"Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein\u2013Barr Virus-Associated Infectious Mononucleosis","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1572-5995(00)80051-4","article-title":"Natural Products as Antiviral Agents","volume":"24","year":"2000","journal-title":"Stud. Nat. Prod. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2038865","DOI":"10.1080\/19490976.2022.2038865","article-title":"The role of key gut microbial metabolites in the development and treatment of cancer","volume":"14","author":"Jaye","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103429","DOI":"10.1016\/j.critrevonc.2021.103429","article-title":"The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses","volume":"165","author":"Jaye","year":"2021","journal-title":"Crit. Rev. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein\u2013Barr Virus Infection and Multiple Sclerosis: A Review","volume":"5","author":"Ascherio","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/1348-0421.12155","article-title":"Regulation of Epstein-Barr virus reactivation from latency","volume":"58","author":"Murata","year":"2014","journal-title":"Microbiol. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Roderburg, C., Krieg, S., Krieg, A., Luedde, T., Kostev, K., and Loosen, S.H. (2022). The Association between Infectious Mononucleosis and Cancer: A Cohort Study of 24,190 Outpatients in Germany. Cancers, 14.","DOI":"10.3390\/cancers14235837"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","article-title":"Regulation of the latent-lytic switch in Epstein\u2013Barr virus","volume":"26","author":"Kenney","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","article-title":"Latency and lytic replication in Epstein\u2013Barr virus-associated oncogenesis","volume":"17","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e00238-19","DOI":"10.1128\/JVI.00238-19","article-title":"Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus","volume":"93","author":"Saha","year":"2019","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.chom.2014.02.011","article-title":"Human Viral Oncogenesis: A Cancer Hallmarks Analysis","volume":"15","author":"Mesri","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1078-0432.CCR-0670-3","article-title":"Epstein-Barr virus and cancer","volume":"10","author":"Thompson","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_37","first-page":"143","article-title":"Epstein-Barr virus infection and the pathogenesis of malignant lymphomas","volume":"30","author":"Niedobitek","year":"1997","journal-title":"Cancer Surv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","article-title":"The Expression Pattern of Epstein-Barr Virus Latent Genes In Vivo Is Dependent upon the Differentiation Stage of the Infected B Cell","volume":"13","author":"Babcock","year":"2000","journal-title":"Immunity"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kamranvar, S.A., and Masucci, M.G. (2017). Regulation of Telomere Homeostasis during Epstein-Barr virus Infection and Immortalization. Viruses, 9.","DOI":"10.3390\/v9080217"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1038\/sj.onc.1207905","article-title":"Epstein\u2013Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras\/PI3K\/Akt pathway","volume":"23","author":"Portis","year":"2004","journal-title":"Oncogene"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1096-9071(199605)49:1<7::AID-JMV2>3.0.CO;2-A","article-title":"Transcriptional expression of Epstein-Barr virus genes and proto-oncogenes in north African nasopharyngeal carcinoma","volume":"49","author":"Djennaoui","year":"1996","journal-title":"J. Med. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/272373a0","article-title":"Persisting oncogenic herpesvirus induced by the tumour promotor TPA","volume":"272","author":"Freese","year":"1978","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein\u2013Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1007\/s12325-019-00995-6","article-title":"Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases","volume":"36","author":"Sliva","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrmicro1273","article-title":"Bacteriocins: Developing innate immunity for food","volume":"3","author":"Cotter","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kesika, P., Sivamaruthi, B.S., Thangaleela, S., and Chaiyasut, C. (2021). The Antiviral Potential of Probiotics\u2014A Review on Scientific Outcomes. Appl. Sci., 11.","DOI":"10.3390\/app11188687"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00421-016-3415-x","article-title":"Effects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: A placebo-controlled, randomized trial","volume":"116","author":"Gleeson","year":"2016","journal-title":"Eur. J. Appl. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1194\/jlr.R067629","article-title":"Short-and medium-chain fatty acids in energy metabolism: The cellular perspective","volume":"57","author":"Wojtczak","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e00188-21","DOI":"10.1128\/IAI.00188-21","article-title":"Short-Chain Fatty Acids as a Potential Treatment for Infections: A Closer Look at the Lungs","volume":"89","author":"Machado","year":"2021","journal-title":"Infect. Immun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1128\/JVI.00722-14","article-title":"Activation and repression of Epstein-Barr virus and Kaposi\u2019s sarcoma-associated herpesvirus lytic cycles by short-and medium-chain fatty acids","volume":"88","author":"Gorres","year":"2014","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40168-021-01028-7","article-title":"Gut microbiota-derived inosine from dietary barley leaf supplementation attenuates colitis through PPAR\u03b3 signaling activation","volume":"9","author":"Li","year":"2021","journal-title":"Microbiome"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e02056-20","DOI":"10.1128\/JVI.02056-20","article-title":"Supplementing the Diet with Sodium Propionate Suppresses the Severity of Viral Immuno-inflammatory Lesions","volume":"95","author":"Sumbria","year":"2021","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/HYPERTENSIONAHA.120.16647","article-title":"Butyrate Regulates COVID-19\u2013Relevant Genes in Gut Epithelial Organoids From Normotensive Rats","volume":"77","author":"Li","year":"2021","journal-title":"Hypertension"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Srinivasan, S., Torres, A., and de Pouplana, L.R. (2021). Inosine in Biology and Disease. Genes, 12.","DOI":"10.3390\/genes12040600"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1515\/acph-2015-0015","article-title":"Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes","volume":"65","author":"Lasek","year":"2015","journal-title":"Acta Pharm."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0192-0561(83)90041-3","article-title":"An in vitro study on the effects of isoprinosine on immune responses in cancer patients","volume":"5","author":"Tsang","year":"1983","journal-title":"Int. J. Immunopharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.intimp.2016.11.023","article-title":"Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: A clinical trial supporting anti-viral indications","volume":"42","author":"Ahmed","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_62","first-page":"155","article-title":"Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS","volume":"24","author":"Bekesi","year":"1987","journal-title":"J. Clin. Lab. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0192-0561(85)90027-X","article-title":"In vitro restoration of immune responses in aging humans by isoprinosine","volume":"7","author":"Tsang","year":"1985","journal-title":"Int. J. Immunopharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4149\/av_2017_01_32","article-title":"The effect of Isoprinosine treatment on persistent infection of Balb\/c mice infected with murine gammaherpesvirus 68","volume":"61","year":"2017","journal-title":"Acta Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0192-0561(85)90025-6","article-title":"Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigens","volume":"7","author":"Sundar","year":"1985","journal-title":"Int. J. Immunopharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-1965-5","article-title":"Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: Analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study","volume":"16","author":"Beran","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Beran, J., \u0160pajdel, M., Katzerov\u00e1, V., Holou\u0161ov\u00e1, A., Maly\u0161, J., Rouskov\u00e1, J.F., and Sl\u00edva, J. (2020). Inosine pranobex significantly decreased the case-fatality rate among PCR positive elderly with SARS-CoV-2 at three nursing homes in the Czech Republic. Pathogens, 9.","DOI":"10.3390\/pathogens9121055"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0168-6445(93)90057-G","article-title":"Genetics of bacteriocins produced by lactic acid bacteria","volume":"12","author":"Klaenhammer","year":"1993","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12602-014-9162-6","article-title":"Antiviral Potential of Lactic Acid Bacteria and Their Bacteriocins","volume":"6","author":"Hober","year":"2014","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ijantimicag.2005.02.005","article-title":"An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4V isolated from soya beans","volume":"25","author":"Todorov","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0166-3542(02)00099-2","article-title":"Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro","volume":"58","author":"Wachsman","year":"2003","journal-title":"Antivir. Res."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"F\u00e9rir, G., Petrova, M.I., Andrei, G., Huskens, D., Hoorelbeke, B., Snoeck, R., Vanderleyden, J., Balzarini, J., Bartoschek, S., and Br\u00f6nstrup, M. (2013). The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal Applications. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064010"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12602-012-9123-x","article-title":"Safety, formulation and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1","volume":"5","author":"Torres","year":"2013","journal-title":"Probiotics Antimicrob."},{"key":"ref_74","first-page":"1","article-title":"Curcumin Inhibits Proliferation of Epstein\u2013Barr Virus-Associated Human Nasopharyngeal Carcinoma Cells by Inhibiting EBV Nuclear Antigen 1 Expression","volume":"2019","author":"Liu","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1248\/bpb.31.2018","article-title":"Inhibition of the Epstein-Barr Virus Lytic Cycle by Andrographolide","volume":"31","author":"Lin","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/phrs.2002.0992","article-title":"Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein\u2013Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis","volume":"45","author":"Kapadia","year":"2002","journal-title":"Pharmacol. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2012.10.006","article-title":"Traditional Chinese herbal medicine as a source of molecules with antiviral activity","volume":"97","author":"Li","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Musarra-Pizzo, M., Pennisi, R., Ben-Amor, I., Mandalari, G., and Sciortino, M. (2021). Antiviral Activity Exerted by Natural Products against Human Viruses. Viruses, 13.","DOI":"10.3390\/v13050828"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/jphp.12436","article-title":"Bioactive natural products with anti-herpes simplex virus properties","volume":"67","author":"Hassan","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ruchawapol, C., Yuan, M., Wang, S.-M., Fu, W.-W., and Xu, H.-X. (2021). Natural Products and Their Derivatives against Human Herpesvirus Infection. Molecules, 26.","DOI":"10.3390\/molecules26206290"},{"key":"ref_81","first-page":"1","article-title":"A Review of the Pharmacological Effects of the Dried Root ofPolygonum cuspidatum(Hu Zhang) and Its Constituents","volume":"2013","author":"Zhang","year":"2013","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_82","first-page":"20","article-title":"Inhibition of the ethanolic extract from Polygonum cuspidatum root on the functions of Epstein-Barr Virus latent membrane protein 1","volume":"21","author":"Yiu","year":"2013","journal-title":"J. Food Drug Anal."},{"key":"ref_83","first-page":"3","article-title":"Inhibitory effects of Polygonum cuspidatum on the Epstein-Barr virus lytic cycle","volume":"19","author":"Yiu","year":"2011","journal-title":"J. Food Drug Anal."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3390\/molecules19011258","article-title":"Inhibition of Epstein-Barr Virus Lytic Cycle by an Ethyl Acetate Subfraction Separated from Polygonum cuspidatum Root and Its Major Component, Emodin","volume":"19","author":"Yiu","year":"2014","journal-title":"Molecules"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Kemboi, D., Peter, X., Langat, M., and Tembu, J. (2020). A review of the ethnomedicinal uses, biological activities, and triterpenoids of Euphorbia species. Molecules, 25.","DOI":"10.3390\/molecules25174019"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1021\/np500988m","article-title":"neo-Clerodane Diterpenoids from Scutellaria barbata with Activity against Epstein\u2013Barr Virus Lytic Replication","volume":"78","author":"Wu","year":"2015","journal-title":"J. Nat. Prod."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"46938","DOI":"10.1039\/C7RA08877A","article-title":"ent-Rosane diterpenoids from Euphorbia milii showing an Epstein\u2013Barr virus lytic replication assay","volume":"7","author":"Liu","year":"2017","journal-title":"RSC Adv."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3892\/or.2017.5489","article-title":"Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3892\/ijo.2016.3502","article-title":"Berberine induces mitochondrial apoptosis of EBV-transformed B cells through p53-mediated regulation of XAF1 and GADD45\u03b1","volume":"49","author":"Park","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1186\/1471-2407-13-619","article-title":"Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts","volume":"13","author":"Tsang","year":"2013","journal-title":"BMC Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"103802","DOI":"10.1016\/j.jff.2020.103802","article-title":"Berberine and ginsenoside Rg3 act synergistically via the MAPK\/ERK pathway in nasopharyngeal carcinoma cells","volume":"66","author":"Zhou","year":"2020","journal-title":"J. Funct. Foods"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1440-1681.2011.05586.x","article-title":"Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents","volume":"39","author":"Wong","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.bbrc.2014.12.023","article-title":"Triptolide inhibits proliferation of Epstein\u2013Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1","volume":"456","author":"Zhou","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13046-018-0865-5","article-title":"Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells","volume":"37","author":"Zhou","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2005-09-3898","article-title":"Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells","volume":"108","author":"Carter","year":"2006","journal-title":"Blood"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.3390\/molecules15107115","article-title":"Inhibitory Effects of Resveratrol on the Epstein-Barr Virus Lytic Cycle","volume":"15","author":"Yiu","year":"2010","journal-title":"Molecules"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.antiviral.2012.09.003","article-title":"Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt\u2019s lymphoma cells by affecting multiple molecular targets","volume":"96","author":"Arena","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Espinoza, J.L., Takami, A., Trung, L.Q., Kato, S., and Nakao, S. (2012). Resveratrol Prevents EBV Transformation and Inhibits the Outgrowth of EBV-Immortalized Human B Cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051306"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-016-0313-9","article-title":"Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin","volume":"24","author":"Wu","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/acs.jnatprod.6b00415","article-title":"Semisynthesis of (\u2212)-Rutamarin Derivatives and Their Inhibitory Activity on Epstein\u2013Barr Virus Lytic Replication","volume":"80","author":"Lin","year":"2017","journal-title":"J. Nat. Prod."},{"key":"ref_101","first-page":"1","article-title":"Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1\/NF-\u03baB\/miR-155\/PU","volume":"17","author":"Wu","year":"2017","journal-title":"1 pathway. BMC Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0006-291X(03)00067-6","article-title":"Inhibition of Epstein\u2013Barr virus lytic cycle by (\u2212)-epigallocatechin gallate","volume":"301","author":"Chang","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/carcin\/bgs364","article-title":"(-)-Epigallocatechin-3-gallate inhibition of Epstein\u2013Barr virus spontaneous lytic infection involves ERK1\/2 and PI3-K\/Akt signaling in EBV-positive cells","volume":"34","author":"Liu","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_104","first-page":"1105","article-title":"(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1","volume":"15","author":"Liu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2008.01.160","article-title":"Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: Structure\u2013activity relationships","volume":"79","author":"Lin","year":"2008","journal-title":"Antivir. Res."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Bentz, G.L., Lowrey, A.J., Horne, D.C., Nguyen, V., Satterfield, A.R., Ross, T.D., Harrod, A.E., Uchakina, O.N., and McKallip, R.J. (2019). Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217578"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2021.12541","article-title":"Triptolide inhibits human telomerase reverse transcriptase by downregulating translation factors SP1 and c-Myc in Epstein-Barr virus-positive B lymphocytes","volume":"21","author":"Long","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"112493","DOI":"10.1016\/j.jep.2019.112493","article-title":"Bioactive constituents of Lindernia crustacea and its anti-EBV effect via Rta expression inhibition in the viral lytic cycle","volume":"250","author":"Tsai","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Wu, C.-C., Chen, M.-S., Cheng, Y.-J., Ko, Y.-C., Lin, S.-F., Chiu, I.-M., and Chen, J.-Y. (2019). Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis. Cancers, 11.","DOI":"10.3390\/cancers11111795"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1021\/acs.orglett.6b00906","article-title":"Filicinic Acid Based Meroterpenoids with Anti-Epstein\u2013Barr Virus Activities from Hypericum japonicum","volume":"18","author":"Hu","year":"2016","journal-title":"Org. Lett."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Wu, R., Le, Z., Wang, Z., Tian, S., Xue, Y., Chen, Y., Hu, L., and Zhang, Y. (2018). Hyperjaponol H, A New Bioactive Filicinic Acid-Based Meroterpenoid from Hypericum japonicum Thunb. ex Murray . Molecules, 23.","DOI":"10.3390\/molecules23030683"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41419-018-0662-2","article-title":"DNMT1 mediates metabolic reprogramming induced by Epstein\u2013Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma","volume":"9","author":"Luo","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"12603","DOI":"10.18632\/oncotarget.3687","article-title":"Quercetin-induced apoptosis prevents EBV infection","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1074\/jbc.RA120.012645","article-title":"The mTOR inhibitor manassantin B reveals a crucial role of mTORC2 signaling in Epstein-Barr virus reactivation","volume":"295","author":"Wang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1099\/vir.0.031609-0","article-title":"Inhibition of the Epstein\u2013Barr virus lytic cycle by protoapigenone","volume":"92","author":"Tung","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.antiviral.2009.12.002","article-title":"Inhibition of the Epstein\u2013Barr virus lytic cycle by moronic acid","volume":"85","author":"Chang","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/np400757k","article-title":"Potential Antiviral Lignans from the Roots of Saururus chinensis with Activity against Epstein\u2013Barr Virus Lytic Replication","volume":"77","author":"Cui","year":"2014","journal-title":"J. Nat. Prod."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4149\/av_2014_01_76","article-title":"The effect of Astragalus polysaccharide on the Epstein-Barr virus lytic cycle","volume":"58","author":"Guo","year":"2014","journal-title":". Acta Virol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1631\/jzus.B1000336","article-title":"Inhibitory activities of microalgal extracts against Epstein-Barr virus DNA release from lymphoblastoid cells","volume":"12","author":"Kok","year":"2011","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2013.07.009","article-title":"Antiviral activity of angelicin against gammaherpesviruses","volume":"100","author":"Cho","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2174\/18715206113139990096","article-title":"Chemoprevention of skin cancer: Effect of Lawsonia inermis L.(Henna) leaf powder and its pigment artifact, lawsone in the Epstein-Barr virus early antigen activation assay and in two-stage mouse skin carcinogenesis models","volume":"13","author":"Kapadia","year":"2013","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.antiviral.2016.05.007","article-title":"Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes","volume":"132","author":"Wu","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1142\/S0192415X16500166","article-title":"Litsea Species as Potential Antiviral Plant Sources","volume":"44","author":"Wang","year":"2016","journal-title":"Am. J. Chin. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"866","DOI":"10.18632\/oncoscience.110","article-title":"Cordycepin is a novel chemical suppressor of Epstein-Barr virus replication","volume":"1","author":"Ryu","year":"2014","journal-title":"Oncoscience"},{"key":"ref_125","first-page":"1","article-title":"Targeting the signaling in Epstein\u2013Barr virus-associated diseases: Mechanism, regulation, and clinical study","volume":"6","author":"Cao","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1158\/1541-7786.MCR-11-0145","article-title":"Resveratrol Inhibits Proliferation and Survival of Epstein Barr Virus\u2013Infected Burkitt\u2019s Lymphoma Cells Depending on Viral Latency Program","volume":"9","author":"Arena","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Ramayanti, O., Brinkkemper, M., Verkuijlen, S.A., Ritmaleni, L., Go, M.L., and Middeldorp, J.M. (2018). Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas. Cancers, 10.","DOI":"10.3390\/cancers10040089"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11101-013-9288-2","article-title":"Protoflavones: A class of unusual flavonoids as promising novel anticancer agents","volume":"13","author":"Hunyadi","year":"2014","journal-title":"Phytochem. Rev."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"V\u00e1gv\u00f6lgyi, M., Girst, G., K\u00fasz, N., \u00d6tv\u00f6s, S.B., F\u00fcl\u00f6p, F., Hohmann, J., Servais, J.-Y., Seguin-Devaux, C., Chang, F.-R., and Chen, M.S. (2019). Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1\u2032-O-isopropyl ether Shows Improved Selectivity Against the Epstein\u2013Barr Virus Lytic Cycle. Int. J. Mol. Sci., 20.","DOI":"10.20944\/preprints201912.0049.v1"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1016\/S0021-9258(18)43667-8","article-title":"Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A","volume":"255","author":"Stirpe","year":"1980","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.antiviral.2019.02.015","article-title":"GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1","volume":"164","author":"Shen","year":"2019","journal-title":"Antivir. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1716\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:06:44Z","timestamp":1760119604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/1716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,15]]},"references-count":131,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24021716"],"URL":"https:\/\/doi.org\/10.3390\/ijms24021716","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,15]]}}}